Follow
Dr. Muniyan Rajiniraja
Dr. Muniyan Rajiniraja
Associate Professor
Verified email at vit.ac.in
Title
Cited by
Cited by
Year
Lauric acid and myristic acid from Allium sativum inhibit the growth of Mycobacterium tuberculosis H37Ra: in silico analysis reveals possible binding to protein …
R Muniyan, J Gurunathan
Pharmaceutical Biology 54 (12), 2814-2821, 2016
302016
Latent tuberculosis: interaction of virulence factors in Mycobacterium tuberculosis
S Sundararajan, R Muniyan
Molecular Biology Reports 48 (8), 6181-6196, 2021
212021
Favorable binding of Quercetin to α-Synuclein as potential target in Parkinson disease: An Insilico approach
HS Baul, M Rajiniraja
Research journal of pharmacy and technology 11 (1), 203-206, 2018
162018
Genetic alterations and clinical dimensions of oral cancer: a review
K Karunakaran, R Muniyan
Molecular Biology Reports 47 (11), 9135-9148, 2020
142020
Molecular Docking Studies of Selected Flavonoids on Inducible Nitric Oxide Synthase (INOS) in Parkinson’s Disease
HS Baul, R Muniyan
Research journal of pharmacy and technology 11 (8), 2018
122018
Andrographis paniculata leaf extracts as potential Naja naja anti-snake venom
A Sivakumar, A Manikandan, M Rajini Raja, G Jayaraman
World J Pharma Pharm Sci 4 (12), 1036-1050, 2015
112015
Bioautography guided screening of selected Indian medicinal plants reveals potent antimycobacterial activity of Allium sativum extracts-implication of non-sulfur compounds in …
M Rajiniraja, G Jayaraman
Int J Pharm Pharm Sci 6, 671-676, 2014
102014
MIA-QSAR based model for bioactivity prediction of flavonoid derivatives as acetylcholinesterase inhibitors
P Muthukumaran, M Rajiniraja
Journal of Theoretical Biology 459, 103-110, 2018
92018
Aug-MIA-QSAR based strategy in bioactivity prediction of a series of flavonoid derivatives as HIV-1 inhibitors
P Muthukumaran, M Rajiniraja
Journal of Theoretical Biology 469, 18-24, 2019
82019
Mechanistic study of the inhibition of monoamine oxidase-B by quercetin as the potential therapeutic strategy for Parkinson’s Disease: An in silico approach
HS Baul, M Rajiniraja
Journal of Computational Methods in Sciences and Engineering, 1-7, 2018
72018
Antimycobacterial activity of potential plant metabolites with emphasis on management of drug resistant Mycobacterium tuberculosis strains
R Muniyan, J Gurunathan
Res J Biotechnol 12, 12, 2017
62017
Identification of allosteric inhibitor against AKT1 through structure-based virtual screening
K Karunakaran, R Muniyan
Molecular Diversity 27 (6), 2803-2822, 2023
42023
In silico binding study of bioactive Hispolon and its Analogues to mycobacterial mtfabH
P Muthukumaran, M Rajiniraja
Research Journal of Pharmacy and Technology 10 (7), 2229-2232, 2017
42017
In vitro inhibition potential of mono‐n‐octyl phthalate on Mycobacterium tuberculosis H37Ra: Possibility of binding to mycobacterial PknB—An in silico approach
M Rajiniraja, A Sivaramakrishna, V Sabareesh, G Jayaraman
Biotechnology and Applied Biochemistry 65 (6), 865-875, 2018
32018
Protein-Protein Interaction of Mutated Agouti Signaling Protein (ASIP) to Melanocortin Receptor 1 (MC1R) in Melanoma Skin Cancer: An Insilico Study
K Karunakaran, JR Malaiyappan, R Muniyan
Research journal of pharmacy and technology 11 (9), 2018
22018
Structure based virtual screening and discovery of novel inhibitors against FabD protein of Mycobacterium tuberculosis
S Sundararajan, K Karunakaran, R Muniyan
Journal of Biomolecular Structure and Dynamics, 1-12, 2023
12023
Comparative study of Insecticide potential of Methyl parathion and diazinon in Drosophila melanogaster.
RM Suman Sahoo, Mausumi Ari Acharyya
Research Journal of Pharmacy and Technology 14 (5), 2649-2652, 2021
12021
In silico investigation of Methyl parathion and Diazinon with different Metabolic protein in Drosophila melanogaster
S Sahoo, ML Rahman, S Mitra, M Rajiniraja
Research Journal of Pharmacy and Technology 14 (7), 3794-3798, 2021
12021
Prediction of alternate drugs for Crizotinib resistant mutated-ALK inhibitors in lung cancer treatment: An In silico approach
M Rajiniraja
Research Journal of Pharmacy and Technology 13 (8), 3643-3647, 2020
12020
In silico mutational study reveal improved interaction between Beta-Hexosaminidase A and GM2 activator essential for the breakdown of GM2 and GA2 Gangliosides on Tay-Sachs disease
K Kapruwan, R Parida, R Muniyan
Research Journal of Pharmacy and Technology 10 (11), 3899-3902, 2017
12017
The system can't perform the operation now. Try again later.
Articles 1–20